New York, New York--(Newsfile Corp. - April 26, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS ...

Shares of Viatris Inc. VTRS rallied 2.82% to $8.03 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.03% to 5,484.77 ...

Viatris Inc., a global healthcare company, announced it has filed applications to the Ministry of Health, Labor and Welfare (MHLW) for approval of Effexor SR capsules (venlafaxine hydrochloride), a ...

Philadelphia, Pennsylvania--(Newsfile Corp. - April 22, 2025) - Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Thanks to David Krumholtz of "The Santa Clause" fame, we've gotten our very first glimpse at the official logo for next year's "Supergirl: Woman of Tomorrow"... or perhaps just "Supergirl"?

Viatris Inc. (NASDAQ:VTRS) is a healthcare company that operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs ...

Sydney (AFP) – In one of his final acts, Pope Francis cleared the way for Papua New Guinea to get its first saint -- an anti-polygamy preacher who died in prison during Japan's World War II ...

Six matches in double round-robin format will be held across six days, with hosts Japan competing alongside Fiji and winners of last year’s Division 2 Qualifier, Papua New Guinea (PNG), where only the ...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...